# NephroGenex, Inc.: Form D filings

NephroGenex, Inc., a pharmaceuticals company in Raleigh, NC, filed 2 Form D notices with the SEC between 2010 and 2015. The latest, on November 13, 2015, reports $5.5 million sold of a $28.5 million offering to 14 investors.

Find out what NephroGenex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NephroGenex%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NephroGenex%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnephrogenex-inc-1338095)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NephroGenex%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NephroGenex%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnephrogenex-inc-1338095)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3200 BEECHLEAF COURT, SUITE 900, Raleigh, NC, 27604
- Phone: (609) 986-1780
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1338095

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 13, 2015 | New notice | $28,500,000 | $5,500,000 | $23,000,000 | 14 | Nov 3, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1338095/000133809515000070/0001338095-15-000070-index.htm) |
| Jul 21, 2010 | New notice | $1,000,000 | $1,000,000 | $0 | 4 | Jul 9, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1338095/000133809510000003/0001338095-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Seltzer | Director |  |
| Eugen Steiner | Director |  |
| Jaikrishna Patel | Executive Officer |  |
| Marco Taglietti | Director |  |
| Pierre Legault | Executive Officer, Director |  |
| James Mitchum | Director |  |
| John Hamill | Executive Officer |  |
| Richard Markham | Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Nov 9, 2015](https://specstream.ai/data/form-d/week/2015-11-09) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what NephroGenex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).